These results coincide with those of Manczak et al. [58], who found reduced OPA1, Mfn1, and Mfn2 gene expression and increased Drp1 and Fis1 expression in postmortem AD human brain tissues. This evidence concerns the gene MFN1 and Alzheimer disease.